These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34558842)

  • 1. Association of Genetic Risk Score With NAFLD in An Ethnically Diverse Cohort.
    Wang J; Conti DV; Bogumil D; Sheng X; Noureddin M; Wilkens LR; Le Marchand L; Rosen HR; Haiman CA; Setiawan VW
    Hepatol Commun; 2021 Oct; 5(10):1689-1703. PubMed ID: 34558842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide association meta-analysis identifies 17 loci associated with nonalcoholic fatty liver disease.
    Chen Y; Du X; Kuppa A; Feitosa MF; Bielak LF; O'Connell JR; Musani SK; Guo X; Kahali B; Chen VL; Smith AV; Ryan KA; Eirksdottir G; Allison MA; Bowden DW; Budoff MJ; Carr JJ; Chen YI; Taylor KD; Oliveri A; Correa A; Crudup BF; Kardia SLR; Mosley TH; Norris JM; Terry JG; Rotter JI; Wagenknecht LE; Halligan BD; Young KA; Hokanson JE; Washko GR; Gudnason V; Province MA; Peyser PA; Palmer ND; Speliotes EK
    Nat Genet; 2023 Oct; 55(10):1640-1650. PubMed ID: 37709864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort
    Anstee QM; Darlay R; Cockell S; Meroni M; Govaere O; Tiniakos D; Burt AD; Bedossa P; Palmer J; Liu YL; Aithal GP; Allison M; Yki-Järvinen H; Vacca M; Dufour JF; Invernizzi P; Prati D; Ekstedt M; Kechagias S; Francque S; Petta S; Bugianesi E; Clement K; Ratziu V; Schattenberg JM; Valenti L; Day CP; Cordell HJ; Daly AK;
    J Hepatol; 2020 Sep; 73(3):505-515. PubMed ID: 32298765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-Wide Association Study of NAFLD Using Electronic Health Records.
    Fairfield CJ; Drake TM; Pius R; Bretherick AD; Campbell A; Clark DW; Fallowfield JA; Hayward C; Henderson NC; Joshi PK; Mills NL; Porteous DJ; Ramachandran P; Semple RK; Shaw CA; Sudlow CLM; Timmers PRHJ; Wilson JF; Wigmore SJ; Harrison EM; Spiliopoulou A
    Hepatol Commun; 2022 Feb; 6(2):297-308. PubMed ID: 34535985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of PNPLA3, TM6SF2 and SAMM50 on the development and severity of non-alcoholic fatty liver disease in children.
    Lee KJ; Moon JS; Kim NY; Ko JS
    Pediatr Obes; 2022 Feb; 17(2):e12852. PubMed ID: 34490745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible Relevance of PNPLA3 and TLL1 Gene Polymorphisms to the Efficacy of PEG-IFN Therapy for HBV-Infected Patients.
    Enomoto H; Aizawa N; Hasegawa K; Ikeda N; Sakai Y; Yoh K; Takata R; Yuri Y; Kishino K; Shimono Y; Ishii N; Takashima T; Nishimura T; Nishikawa H; Iwata Y; Iijima H; Nishiguchi S
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32349377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models.
    Longo M; Meroni M; Paolini E; Erconi V; Carli F; Fortunato F; Ronchi D; Piciotti R; Sabatini S; Macchi C; Alisi A; Miele L; Soardo G; Comi GP; Valenti L; Ruscica M; Fracanzani AL; Gastaldelli A; Dongiovanni P
    Cell Mol Gastroenterol Hepatol; 2022; 13(3):759-788. PubMed ID: 34823063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variants associated with metabolic dysfunction-associated fatty liver disease in western China.
    Liao S; An K; Liu Z; He H; An Z; Su Q; Li S
    J Clin Lab Anal; 2022 Sep; 36(9):e24626. PubMed ID: 35881683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of a genetic risk score to ethnic differences in fatty liver disease.
    Kubiliun MJ; Cohen JC; Hobbs HH; Kozlitina J
    Liver Int; 2022 Oct; 42(10):2227-2236. PubMed ID: 35620859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population.
    Mazo DF; Malta FM; Stefano JT; Salles APM; Gomes-Gouvea MS; Nastri ACS; Almeida JR; Pinho JRR; Carrilho FJ; Oliveira CP
    Ann Hepatol; 2019; 18(3):466-471. PubMed ID: 31054980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran program.
    Serper M; Vujkovic M; Kaplan DE; Carr RM; Lee KM; Shao Q; Miller DR; Reaven PD; Phillips LS; O'Donnell CJ; Meigs JB; Wilson PWF; Vickers-Smith R; Kranzler HR; Justice AC; Gaziano JM; Muralidhar S; Pyarajan S; DuVall SL; Assimes TL; Lee JS; Tsao PS; Rader DJ; Damrauer SM; Lynch JA; Saleheen D; Voight BF; Chang KM;
    PLoS One; 2020; 15(8):e0237430. PubMed ID: 32841307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PARVB and HSD17B13 variants are associated with nonalcoholic fatty liver disease in children.
    Lee KJ; Moon JS; Lim JG; Huh H; Ahn JE; Kim L; Kim NY; Ko JS
    J Gastroenterol Hepatol; 2024 Jun; 39(6):1172-1182. PubMed ID: 38418429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants in GCKR and PNPLA3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals.
    Lin YC; Chang PF; Chang MH; Ni YH
    Am J Clin Nutr; 2014 Apr; 99(4):869-74. PubMed ID: 24477042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the association of a variant in PNPLA3 and TM6SF2 with fibrosis progression in patients with chronic hepatitis C infection after eradication: A retrospective study.
    Kang Q; Xu J; Luo H; Tan N; Chen H; Cheng R; Pan J; Han Y; Yang Y; Liu D; Xi H; Yu M; Xu X
    Gene; 2022 Apr; 820():146235. PubMed ID: 35143946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diet Associations With Nonalcoholic Fatty Liver Disease in an Ethnically Diverse Population: The Multiethnic Cohort.
    Noureddin M; Zelber-Sagi S; Wilkens LR; Porcel J; Boushey CJ; Le Marchand L; Rosen HR; Setiawan VW
    Hepatology; 2020 Jun; 71(6):1940-1952. PubMed ID: 31553803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of a genetic risk score to clinical prediction of hepatic steatosis in obese children and adolescents.
    Zusi C; Mantovani A; Olivieri F; Morandi A; Corradi M; Miraglia Del Giudice E; Dauriz M; Valenti L; Byrne CD; Targher G; Maffeis C
    Dig Liver Dis; 2019 Nov; 51(11):1586-1592. PubMed ID: 31255630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American Ancestry Is a Risk Factor for Suspected Nonalcoholic Fatty Liver Disease in Hispanic/Latino Adults.
    Kallwitz ER; Tayo BO; Kuniholm MH; Cai J; Daviglus M; Cooper RS; Cotler SJ
    Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2301-2309. PubMed ID: 30743004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GWAS and enrichment analyses of non-alcoholic fatty liver disease identify new trait-associated genes and pathways across eMERGE Network.
    Namjou B; Lingren T; Huang Y; Parameswaran S; Cobb BL; Stanaway IB; Connolly JJ; Mentch FD; Benoit B; Niu X; Wei WQ; Carroll RJ; Pacheco JA; Harley ITW; Divanovic S; Carrell DS; Larson EB; Carey DJ; Verma S; Ritchie MD; Gharavi AG; Murphy S; Williams MS; Crosslin DR; Jarvik GP; Kullo IJ; Hakonarson H; Li R; ; Xanthakos SA; Harley JB
    BMC Med; 2019 Jul; 17(1):135. PubMed ID: 31311600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Membrane-bound O-Acyltransferase7 rs641738 Variant in Pediatric Nonalcoholic Fatty Liver Disease.
    Di Sessa A; Umano GR; Cirillo G; Del Prete A; Iacomino R; Marzuillo P; Del Giudice EM
    J Pediatr Gastroenterol Nutr; 2018 Jul; 67(1):69-74. PubMed ID: 29601441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Polymorphisms of PNPLA3 and SAMM50 Are Associated with Nonalcoholic Fatty Liver Disease in a Korean Population.
    Chung GE; Lee Y; Yim JY; Choe EK; Kwak MS; Yang JI; Park B; Lee JE; Kim JA; Kim JS
    Gut Liver; 2018 May; 12(3):316-323. PubMed ID: 29271184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.